5-symptom Digestive Relief Suspension
NDC Package 11673-291-08

11-digit billing NDC: 11673029108

Package Information

5-symptom Digestive Relief (bismuth subsalicylate) suspension is uses relieves ■ travelers’ diarrhea■ diarrhea■ upset stomach due to overindulgence in food and drink, including: ■ heartburn ■ indigestion ■ nausea ■ gas ■ belching ■ fullness. This formulation utilizes a suspension delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-291 and is authorized under FDA application M008.

Identification & Billing

NDC Package Code
11673-291-08
Package Description
2 BOTTLE, PLASTIC in 1 PACKAGE / 473 mL in 1 BOTTLE, PLASTIC (11673-291-07)
Product Code
11-Digit Billing Format
11673029108
RxNorm Crosswalk
  • RxCUI: 308762 - bismuth subsalicylate 525 MG in 30 mL Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 17.5 MG/ML Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 1.75 % Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 262 MG per 15 ML Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 524 MG per 30 ML Oral Suspension

Clinical Specifications

Proprietary Name
5-symptom Digestive Relief
Non-Proprietary Name
Bismuth Subsalicylate
Substance Name
Bismuth Subsalicylate
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Uses relieves ■ travelers’ diarrhea■ diarrhea■ upset stomach due to overindulgence in food and drink, including: ■ heartburn ■ indigestion ■ nausea ■ gas ■ belching ■ fullness

Regulatory & Marketing

Labeler Name
Target Corporation
Product Type
Human Otc Drug
FDA Application #
M008
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-16-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (11673-291). Click a package code to view its specific billing and regulatory data.

236 mL in 1 BOTTLE, PLASTIC
473 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 11673-291-08 identifies a specific commercial package of 2 bottle, plastic in 1 package / 473 ml in 1 bottle, plastic (11673-291-07) of 5-symptom Digestive Relief, a human over the counter drug labeled by Target Corporation. This suspension is formulated for oral use and contains bismuth subsalicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on June 16, 2025. The current certification is valid through December 31, 2026.

How is this Target Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673029108. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
11673-291-08
11-Digit CMS (5-4-2)
11673-0291-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.